PMN-400

N/A

Report date: 2024/03/04 16:09:47

Base Information

Drug NamePMN-400

Drug Alias NameAlpha-synuclein vaccine (ProMIS Neurosciences)PMN-400PMN400

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Conjugated vaccineVaccines > Development/production technology > Synthetic peptide vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsParkinson Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesProMIS Neurosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesProMIS Neurosciences Inc

Inactive CompaniesN/A

Active IndicationsParkinson Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A